| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -2,2 k € | +40.7% | -3,7 k € | -672.8% | -472,3 € | +61.5% | -1,2 k € | -142.9% | 2,9 k € | -60.7% | 7,3 k € | -68.6% | 23,1 k € | +440.5% | 4,3 k € | -65.0% | 12,2 k € | -60.4% | 30,9 k € | +5.6% | 29,3 k € | -24.2% | 38,6 k € | -34.4% | 58,8 k € | +55.4% | 37,8 k € | -29.8% | 53,9 k € | +7.7% | 50,0 k € | +109.1% | 23,9 k € | +3680.3% | 633,0 € | -21.2% | 803,1 € | |
| EBITDA | -2,6 k € | +36.8% | -4,0 k € | -211.9% | -1,3 k € | +47.4% | -2,5 k € | -447.5% | 708,2 € | -88.0% | 5,9 k € | -72.7% | 21,5 k € | +712.0% | 2,7 k € | -76.3% | 11,2 k € | -61.1% | 28,7 k € | +3.1% | 27,8 k € | -19.5% | 34,6 k € | -39.4% | 57,1 k € | +55.4% | 36,7 k € | -30.0% | 52,5 k € | +9.5% | 47,9 k € | +104.9% | 23,4 k € | +8929.9% | -265,0 € | +45.5% | -486,6 € | |
| Operating profit | -9,2 k € | +13.9% | -10,6 k € | +6.8% | -11,4 k € | -50.7% | -7,6 k € | +48.4% | -14,7 k € | -2013.0% | 768,9 € | -95.0% | 15,5 k € | +439.0% | -4,6 k € | +7.5% | -4,9 k € | -142.4% | 11,6 k € | +14.2% | 10,2 k € | -49.4% | 20,1 k € | -49.8% | 40,1 k € | +125.2% | 17,8 k € | -45.2% | 32,5 k € | +6.6% | 30,5 k € | +295.9% | 7,7 k € | +172.9% | -10,6 k € | -36.7% | -7,7 k € | |
| Profit/loss | -9,2 k € | +16.0% | -11,0 k € | +4.8% | -11,6 k € | -58.2% | -7,3 k € | +42.7% | -12,7 k € | -49584.1% | -25,7 € | -100.2% | 11,6 k € | +279.6% | -6,4 k € | +8.0% | -7,0 k € | -210.6% | 6,3 k € | +63.0% | 3,9 k € | -18.8% | 4,8 k € | -79.4% | 23,2 k € | +182.7% | 8,2 k € | -51.7% | 17,0 k € | -7.4% | 18,4 k € | +311.2% | 4,5 k € | +139.2% | -11,4 k € | -36.7% | -8,3 k € | |
| Equity | 25,2 k € | -26.8% | 34,4 k € | -24.2% | 45,4 k € | -20.3% | 57,0 k € | -11.4% | 64,3 k € | -16.5% | 77,1 k € | -0.0% | 77,1 k € | +17.7% | 65,5 k € | -9.0% | 72,0 k € | -8.9% | 79,0 k € | +8.7% | 72,6 k € | +5.7% | 68,7 k € | +7.5% | 64,0 k € | +57.0% | 40,7 k € | +25.3% | 32,5 k € | +109.8% | 15,5 k € | +637.2% | -2,9 k € | +60.8% | -7,4 k € | -281.3% | 4,1 k € | |
| Total assets | 28,2 k € | -19.0% | 34,8 k € | -26.4% | 47,3 k € | -19.8% | 59,0 k € | -32.2% | 87,0 k € | -17.7% | 105,6 k € | -9.3% | 116,5 k € | -10.4% | 130,1 k € | -12.2% | 148,2 k € | -10.5% | 165,7 k € | -13.2% | 190,9 k € | +17.9% | 161,9 k € | -9.3% | 178,6 k € | +11.6% | 160,0 k € | +5.2% | 152,1 k € | +11.4% | 136,5 k € | +5.7% | 129,1 k € | -4.5% | 135,2 k € | +138.9% | 56,6 k € | |
| Cash | 266,8 € | +1.7% | 262,4 € | -79.4% | 1,3 k € | +66.1% | 766,1 € | -57.7% | 1,8 k € | — | 4,6 k € | +5448.1% | 83,2 € | -98.2% | 4,7 k € | -55.7% | 10,7 k € | -54.6% | 23,6 k € | +589.6% | 3,4 k € | -79.2% | 16,4 k € | +22.4% | 13,4 k € | -30.0% | 19,2 k € | +121.5% | 8,7 k € | +738.9% | 1,0 k € | -51.0% | 2,1 k € | -65.9% | 6,2 k € | |||
| Debts | 3,0 k € | +647.8% | 406,4 € | -78.3% | 1,9 k € | -4.8% | 2,0 k € | -91.3% | 22,7 k € | -20.7% | 28,6 k € | -27.6% | 39,4 k € | -38.9% | 64,6 k € | -15.3% | 76,3 k € | -12.0% | 86,7 k € | -26.7% | 118,3 k € | +26.9% | 93,2 k € | -18.7% | 114,6 k € | -3.9% | 119,3 k € | -0.3% | 119,6 k € | -1.2% | 121,0 k € | -8.3% | 132,0 k € | -4.9% | 138,8 k € | +164.3% | 52,5 k € | |
Private company with limited liability · Tienen · incorporated on 13/03/2006
Private company with limited liability loss-making in the latest fiscal year.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
VERHOEVEN, NEYT EN DOCHTERS is a Private company with limited liability incorporated in 2006. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Tienen.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.